Reza Jabbari Selected Research

Hemorrhage

11/2023	Bleeding risk and P2Y12 inhibitors in all-comer patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: a single-centre cohort study.
1/2021	Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction.
12/2017	Prasugrel vs. clopidogrel in contemporary Western European patients with acute coronary syndromes receiving drug-eluting stents: Comparative cost-effectiveness analysis from the BASKET-PROVE cohorts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reza Jabbari Research Topics

Disease

11	ST Elevation Myocardial Infarction 11/2023 - 01/2015
5	Ventricular Fibrillation 10/2023 - 01/2015
4	Myocardial Infarction 11/2021 - 01/2013
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 04/2024 - 01/2017
3	Hemorrhage 11/2023 - 12/2017
3	Atrial Fibrillation 01/2021 - 01/2017
2	Heart Failure 04/2023 - 01/2022
2	COVID-19 10/2022 - 11/2021
2	Disease Susceptibility (Diathesis) 05/2022 - 01/2022
2	Brugada Syndrome 05/2022 - 01/2022
2	Ischemic Stroke 11/2021 - 01/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020 - 11/2018
1	Acute-Phase Reaction 10/2023
1	Infarction (Infarctions) 10/2023
1	Ischemia 10/2023
1	Cicatrix (Scar) 01/2023
1	Reperfusion Injury 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Hypokalemia 01/2020
1	Coronary Disease (Coronary Heart Disease) 01/2019
1	Acute Coronary Syndrome 12/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2017
1	Death (Near-Death Experience) 01/2017
1	Sudden Death 01/2017
1	Leukocytosis (Pleocytosis) 11/2016
1	Neoplasms (Cancer) 08/2015
1	Sudden Infant Death (SID) 06/2015
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2014
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 06/2013
1	Heart Diseases (Heart Disease) 03/2013
1	Osteoporosis 03/2010

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2019
3	Clopidogrel (Plavix)FDA Link 11/2023 - 12/2017
3	Prasugrel Hydrochloride FDA Link 11/2023 - 12/2017
3	Sodium Channels (Sodium Channel)IBA 05/2022 - 06/2015
2	TicagrelorIBA 11/2023 - 11/2021
1	omega-Chloroacetophenone (Mace)IBA 11/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 11/2023
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	Blood Proteins (Serum Proteins)IBA 10/2023
1	GadoliniumIBA 01/2023
1	danegaptideIBA 01/2023
1	pro-brain natriuretic peptide (1-76)IBA 10/2022
1	TroponinIBA 10/2022
1	AnticoagulantsIBA 01/2021
1	dimemorfan (AT 17)IBA 01/2021
1	PotassiumIBA 01/2020
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2019
1	LipidsIBA 11/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	C-Reactive ProteinIBA 11/2016
1	SodiumIBA 06/2015
1	Niacin (Nicotinic Acid)FDA LinkGeneric 06/2013

Therapy/Procedure

9	Percutaneous Coronary Intervention 11/2023 - 01/2015
3	Therapeutics 11/2023 - 01/2021
3	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 04/2023 - 01/2013
2	Stents 11/2023 - 12/2017
1	Polypharmacy 04/2024
1	Catheters 10/2023
1	Thrombectomy 01/2022
1	Ischemic Postconditioning 01/2022
1	Defibrillators (Defibrillator) 10/2020
1	Resuscitation 01/2020
1	Drug-Eluting Stents 12/2017
1	Drug Therapy (Chemotherapy) 01/2017
1	Radiotherapy 08/2015
1	Transplantation 01/2014
1	Injections 03/2010